<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35285072</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8249</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Annals of neurology</Title><ISOAbbreviation>Ann Neurol</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19.</ArticleTitle><Pagination><StartPage>772</StartPage><EndPage>781</EndPage><MedlinePgn>772-781</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ana.26350</ELocationID><Abstract><AbstractText Label="OBJECTIVE">As SARS-CoV-2 is known to invade neural cell mitochondria, a plasma system for quantifying central nervous system proteins in living humans was used to investigate neuropathogenic mechanisms of long-COVID-19.</AbstractText><AbstractText Label="METHODS">SARS-CoV-2 proteins and mitochondrial proteins (MPs) in enriched plasma neuron-derived extracellular vesicles (NDEVs) and astrocyte-derived EVs (ADEVs) were quantified in resolved acute COVID-19 without post-acute sequelae of SARS-CoV-2 (PASC), PASC without neuropsychiatric manifestations (NP), PASC with NP and healthy controls.</AbstractText><AbstractText Label="RESULTS">NDEV and ADEV mean levels of SARS-CoV-2&#x2009;S1 and nucleocapsid (N) proteins were higher in all PASC sub-groups than controls, but only N levels were higher in PASC with than without NP. Exosome marker CD81-normalized NDEV mean levels of subunit 6 of MP respiratory chain complex I and subunit 10 of complex III, and neuroprotective MPs Humanin and mitochondrial open-reading frame of the 12S rRNA-c (MOTS-c) all were decreased significantly in PASC with NP but not in PASC without NP relative to controls. NDEV levels of MPs voltage-dependent anion-selective channel protein 1 (VDAC1) and N-methyl-D-aspartate receptor 1 (NMDAR1) were decreased in PASC without and with NP, whereas those of calcium channel MPs mitochondrial calcium uniporter (MCU), sodium/calcium exchanger (NCLX) and leucine zipper EF-hand containing transmembrane 1 protein (LETM1) were decreased only in PASC with NP. ADEV levels of MCU and NCLX only were increased in PASC without and with NP.</AbstractText><AbstractText Label="INTERPRETATION">Abnormal NDEV and ADEV levels of SARS-CoV-2&#xa0;N and S1 protein and MPs correlate with NP and may be biomarkers for long-COVID prognostics and therapeutic trials. ANN NEUROL 2022;91:772-781.</AbstractText><CopyrightInformation>&#xa9; 2022 American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peluso</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deeks</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustapic</LastName><ForeName>Maja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Intramural Research Program, National Institute on Aging, Biomedical Research Center, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapogiannis</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Intramural Research Program, National Institute on Aging, Biomedical Research Center, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henrich</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Division of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Sarah A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-8642-1468</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoh</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jessica Y</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Enrique O</ForeName><Initials>EO</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>J Daniel</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Jeffrey N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goetzl</LastName><ForeName>Edward J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-0706-5371</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department, Campus for Jewish Living, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AI157875</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI141003</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AI147159</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AI126521</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI146268</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Neurol</MedlineTA><NlmUniqueID>7707449</NlmUniqueID><ISSNLinking>0364-5134</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="Y">Exosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="N">Mitochondrial Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>No authors declare any conflict&#x2010;of&#x2010;interest except for Dr. Goetzl who has filed an application covering this lab methodology with the US Patent and Trademark Office.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35285072</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="doi">10.1002/ana.26350</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, et al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ glob Health 2021;6:e005427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, et al. 6&#x2010;month neurological and psychiatric outcomes in 236 379 survivors of COVID&#x2010;19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021;8:416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz&#x2010;Mondolfi A, Bryce C, Grimes Z, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus&#x2010;2 (SARS&#x2010;CoV&#x2010;2). J Med Virol 2020;92:699&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero JI, Barragan LA, Martinez JD, et al. Central and peripheral nervous system involvement by COVID&#x2010;19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infect Dis 2021;21:515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8170436</ArticleId><ArticleId IdType="pubmed">34078305</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Wang K, Yu J, et al. The spatial and cell&#x2010;type distribution of SARS&#x2010;CoV&#x2010;2 receptor ACE2 in the human and mouse brains. Front Neurol 2020;11:573095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579:265&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K, Zou J, Chang HY. RNA&#x2010;GPS predicts SARS&#x2010;CoV&#x2010;2 RNA residency to host mitochondria and nucleolus. Cell Syst 2020;11(1):102&#x2013;108 e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7305881</ArticleId><ArticleId IdType="pubmed">32673562</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Jang GM, Bouhaddou M, et al. A SARS&#x2010;CoV&#x2010;2 protein interaction map reveals targets for drug repurposing. Nature 2020;583:459&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhao X, Li J, et al. Genomic characterisation andepidemiology of 2019 novel coronavirus: implications for virus origins andreceptor binding. Lancet 2020;395(10224):565&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SM, Kleiboeker SB. Porcine reproductive and respiratory syndrome virus induces apoptosis through a mitochondria&#x2010;mediated pathway. Virology 2007;365:419&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127477</ArticleId><ArticleId IdType="pubmed">17488647</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Han Y, Shi H, et al. Swine acute diarrhea syndrome coronavirus&#x2010;induced apoptosis is caspase&#x2010; and cyclophilin D&#x2010; dependent. Emerg Microbes Infect 2020;9:439&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7054944</ArticleId><ArticleId IdType="pubmed">32090691</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti P, Ilamathi HS, Todkar K, Germain M. Mitochondria targeted viral replication and survival strategies&#x2010;prospective on SARS&#x2010;CoV&#x2010;2. Front Pharmacol 2020;11:578599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7485471</ArticleId><ArticleId IdType="pubmed">32982760</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustapic M, Eitan E, Werner JK Jr, et al. Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes. Front Neurosci 2017;11:278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5439289</ArticleId><ArticleId IdType="pubmed">28588440</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiandaca MS, Kapogiannis D, Mapstone M, et al. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case&#x2010;control study. Alzheimers Dement 2015;11:600&#x2013;7 e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4329112</ArticleId><ArticleId IdType="pubmed">25130657</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl EJ, Mustapic M, Kapogiannis D, et al. Cargo proteins of plasma astrocyte&#x2010;derived exosomes in Alzheimer's disease. FASEB J 2016;30:3853&#x2013;3859.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5067254</ArticleId><ArticleId IdType="pubmed">27511944</ArticleId></ArticleIdList></Reference><Reference><Citation>Winston CN, Goetzl EJ, Akers JC, et al. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. Alzheimers Dement (Amst) 2016;3:63&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4925777</ArticleId><ArticleId IdType="pubmed">27408937</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl EJ, Abner EL, Jicha GA, et al. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease. FASEB J 2018;32:888&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5888398</ArticleId><ArticleId IdType="pubmed">29025866</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl EJ, Schwartz JB, Abner EL, et al. High complement levels in astrocyte&#x2010;derived exosomes of Alzheimer disease. Ann Neurol 2018;83:544&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867263</ArticleId><ArticleId IdType="pubmed">29406582</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl EJ, Elahi FM, Mustapic M, et al. Altered levels of plasma neuron&#x2010;derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury. FASEB J 2019;33:5082&#x2013;5088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6436652</ArticleId><ArticleId IdType="pubmed">30605353</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl EJ, Ledreux A, Granholm AC, et al. Neuron&#x2010;derived exosome proteins may contribute to progression from repetitive mild traumatic brain injuries to chronic traumatic encephalopathy. Front Neurosci 2019;13:452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6517542</ArticleId><ArticleId IdType="pubmed">31133789</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapogiannis D, Mustapic M, Shardell MD, et al. Association of Extracellular Vesicle Biomarkers with Alzheimer Disease in the Baltimore longitudinal study of aging. JAMA Neurol 2019;76:1340&#x2013;1351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632160</ArticleId><ArticleId IdType="pubmed">31305918</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl EJ, Srihari VH, Guloksuz S, et al. Decreased mitochondrial electron transport proteins and increased complement mediators in plasma neural&#x2010;derived exosomes of early psychosis. Transl Psychiatry 2020;10:361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588411</ArticleId><ArticleId IdType="pubmed">33106473</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl EJ, Wolkowitz OM, Srihari VH, et al. Abnormal levels of mitochondrial proteins in plasma neuronal extracellular vesicles in major depressive disorder. Mol Psychiatry 2021;26:7355&#x2013;7362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8872999</ArticleId><ArticleId IdType="pubmed">34471251</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl EJ, Srihari VH, Guloksuz S, et al. Neural cell&#x2010;derived plasma exosome protein abnormalities implicate mitochondrial impairment in first episodes of psychosis. FASEB J 2021;35:e21339.</Citation><ArticleIdList><ArticleId IdType="pubmed">33454965</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Kelly JD, Lu S, et al. Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS&#x2010;CoV&#x2010;2 infection: Cohort description and approaches for measurement. Open Forum Infect Dis 2022;9(2):ofab640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L, et al. Long&#x2010;term SARS&#x2010;CoV&#x2010;2&#x2010;specific immune and inflammatory responses in individuals recovering from COVID19 with and without postacute symptoms. Cell Rep 2021;36(6):109518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Takahashi S, Hakim J, et al. SARS&#x2010;CoV&#x2010;2 antibody magnitude and detectability are driven by disease severity, timing, and assay. Sci Adv 2021;7(31).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324059</ArticleId><ArticleId IdType="pubmed">34330709</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin R, de Charro F. EQ&#x2010;5D: a measure of health status from the EuroQol group. Ann Med 2001;33:337&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">11491192</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Strine TW, Spitzer RL, et al. The PHQ&#x2010;8 as a measure of current depression in the general population. J Affect Disord 2009;114:163&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">18752852</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD&#x2010;7. Arch Intern Med 2006;166:1092&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ, et al. Characterization and biomarker analyses of post&#x2010;COVID&#x2010;19 complications and neurological manifestations. Cell 2021;10:386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao PJ, Eren E, Goetzl EJ, Kapogiannis D. Mitochondrial electron transport chain protein abnormalities detected in plasma extracellular vesicles in Alzheimer's disease. Biomedicine 2021;9:1587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8615874</ArticleId><ArticleId IdType="pubmed">34829816</ArticleId></ArticleIdList></Reference><Reference><Citation>Camara AKS, Zhou Y, Wen PC, et al. Mitochondrial VDAC1: a key gatekeeper as potential therapeutic target. Front Physiol 2017;8:460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491678</ArticleId><ArticleId IdType="pubmed">28713289</ArticleId></ArticleIdList></Reference><Reference><Citation>Korde AS, Maragos WF. Identification of an N&#x2010;methyl&#x2010;D&#x2010;aspartate receptor in isolated nervous system mitochondria. J Biol Chem 2012;287:35192&#x2013;35200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3471715</ArticleId><ArticleId IdType="pubmed">22918829</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado&#x2010;Peraza F, Nogueras&#x2010;Ortiz CJ, Volpert O, et al. Neuronal and astrocytic extracellular vesicle biomarkers in blood reflect brain pathology in mouse models of Alzheimer's disease. Cell 2021;10:993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146429</ArticleId><ArticleId IdType="pubmed">33922642</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok WM, Tajkhorshid E, Camara AKS. Editorial: mitochondrial exchangers and transporters in cell survival and death. Front Physiol 2021;12:745353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8456120</ArticleId><ArticleId IdType="pubmed">34566705</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbani A, Prosdocimi E, Carrer A, et al. Mitochondrial ion channels of the inner membrane and their regulation in cell death signaling. Front Cell Dev Biol 2020;8:620081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7874202</ArticleId><ArticleId IdType="pubmed">33585458</ArticleId></ArticleIdList></Reference><Reference><Citation>Palty R, Silverman WF, Hershfinkel M, et al. NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc Natl Acad Sci U S A 2010;107:436&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2806722</ArticleId><ArticleId IdType="pubmed">20018762</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadiya P, Kolmetzky DW, Tomar D, et al. Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer's disease. Nat Commun 2019;10:3885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6715724</ArticleId><ArticleId IdType="pubmed">31467276</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesce E, Manfrini N, Cordiglieri C, et al. Exosomes recovered from the plasma of COVID&#x2010;19 patients expose SARS&#x2010;CoV&#x2010;2 spike&#x2010;derived fragments and contribute to the adaptive immune response. Front Immunol 2021;12:785941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8801440</ArticleId><ArticleId IdType="pubmed">35111156</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>